MedMiraJul 14, 20223 minMedMira Strengthens and Expands BoardHalifax, Nova Scotia, 14 July, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the appointment of Ms. Pascale Nini to the...
MedMiraJun 30, 20221 minMultiplo® Product Line - A Simple Solution in OneMedMira's unique Multiplo® Product Line: Did you know, MedMira is working with a number of cruise lines which offer MedMira's Multiplo®...
MedMiraJun 5, 20224 minMedMira Receives Patent for its Unique Quantitative Diagnostic SystemHalifax, Nova Scotia, June 6, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450)...
MedMiraMay 26, 20222 minUpdate on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European MarketHalifax, Nova Scotia, 27 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe...
MedMiraMay 19, 20222 minVYRA™ Product Line UpdateHalifax, Nova Scotia, 20 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for...
MedMiraMay 17, 20221 minTest yourself in a smart wayA fact sheet for the importance of testing for both TP/nTP. Multiplo Compete Syphilis (TP/nTP) Antibody Test - testing was never so easy...